Tests a walking exoskeleton device in children with neurodevelopmental disorders and movement problems
Tests a robotic walking device for children and teens with brain development conditions.
Plain-language title generated from the registry record
Registry title: Safety, Usability, and Effectiveness of a Gait Exoskeleton for Children and Adolescents With Neurodevelopmental Disorders.
Key facts
- Where
- Mexico City, MexicoSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children and teenagers aged 2 to 17 to test a robotic walking-training device. One group has no neurodevelopmental disorder; another has one such as CP, NMD, LM or MS.
- Age
- 2 to 17 years
- Sex
- All sexes can join.
- Disease stage
- Phase 1: a diagnosed neurodevelopmental disorder such as CP, NMD, LM or MS. Phase 0: no such diagnosis.
Main reasons for not taking part
- Any medical reason not to stand or walk
- Weight above 60 kg (132 lb)
- Hip or knee contracture greater than 20 degrees
- Skin changes where the device touches the body
- Allergy to materials of the device (cotton, nylon, polyester, PPS, PEEK, ABS)
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 2 and 17 years old?
Source: NCT07159360, who can take part
Where in Mexico
- Asociación Pro Personas con Paralisis Cerebral (APAC-IAP)Mexico City, MexicoContact: Mayra Patricia Estrella PiñónNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- MarsiBionics
- Trial code
- NCT07159360
- Record updated
- 8 September 2025
- Original description
Neurodevelopmental disorders often result in abnormal development of the Central Nervous System (CNS), frequently causing motor dysfunctions such as the inability to stand and walk. CLINICAL EXPLORER is a clinical-use robotic device for gait training, representing the evolution of the ATLAS 2030 exoskeleton and the EXPLORER device for home use. The aim of this study is to evaluate the safety and usability of CLINICAL EXPLORER .Read full original descriptionShow less
Safety, Usability, and Effectiveness of a Gait Exoskeleton for Children and Adolescents With Neurodevelopmental Disorders.
Neurodevelopmental disorders often result in abnormal development of the Central Nervous System (CNS), frequently causing motor dysfunctions such as the inability to stand and walk. CLINICAL EXPLORER is a clinical-use robotic device for gait training, representing the evolution of the ATLAS 2030 exoskeleton and the EXPLORER device for home use. The aim of this study is to evaluate the safety and usability of CLINICAL EXPLORER .
Inclusion: Age between 2 and 17 years; Consent from the participant or legal guardian to participate in the study; No diagnosis of neurodevelopmental disorders such as CP, NMD, LM, or MS. Inclusion Criteria for Phase 1; Age between 2 and 17 years; Consent from the participant or legal guardian to participate in the study; Diagnosis of neurodevelopmental disorders such as CP, NMD, LM, or MS. Inclusion Criteria Related to the EXPLORER CLINICAL Device Characteristics; Medical authorization to stand upright and perform weight-bearing gait training; Weight less than or equal to 60 kg; Hip width less than or equal to 40 cm; Distance from the hip joint center to the knee joint center: 21 cm - 36 cm; Distance from the knee joint center to the ankle joint center: 20 - 35 cm; EU shoe size less than or equal to 40.
Exclusion: Allergy to any of the materials of the EXPLORER CLÍNICO: cotton, nylon, polyester, PPS, PEEK, or ABS. The materials used in EXPLORER CLÍNICO that were not previously used in ATLAS 2030, a medical device certified by the AEMPS, are PPS, PEEK, and ABS; History of fracture without trauma; Presence of other conditions that cause exercise intolerance (such as uncontrolled hypertension, coronary artery diseases, arrhythmia, congestive heart failure, severe pulmonary disease); Behavioral disorders that interfere with proper use of the device, such as impulsivity; Any medical contraindication for standing or walking; Presence of non-reducible contractures or heterotopic ossification above the degrees allowed by the device and/or outside the trajectory imposed by the device; Spasticity (MAS) = 4 in lower limbs at the time of device use; Structured hip and/or knee contracture greater than 20 degrees; Inability to stand or walk with more than 5 degrees of hip abduction; Inability to achieve 5 degrees of dorsal ankle flexion from the neutral position with or without orthosis; Tibial leg length discrepancy that cannot be mitigated with the use of a foot wedge; Skin alterations in areas of contact with the device.